Excellagen
Commercial- Indications
- Wound healing, Diabetic ulcers, Pressure ulcers, Venous ulcers
Company intelligence / Profile preview
Olaregen Therapeutix
New York City, New York, United Statesolaregen.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Olaregen’s lead product Excellagen® is FDA 510K cleared as a flowable dermal matrix for a broad array of dermal wounds. It is commercially available in the US with ongoing international expansion. Early clinical data support its efficacy in promoting healing across multiple wound types. The company is also developing pipeline products targeting bone/joint regeneration and rare diseases such as Ehlers-Danlos syndrome.
- Therapeutic areas
- EndocrinologyRare DiseasesDermatologyRheumatologyCardiovascularInfectious Diseases
- Modalities
- DeviceBiologicPlatform
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Nexgen Medical Sdn Bhd – exclusive distributor for Malaysia/Southeast Asia region
Beyond the preview
Go deeper on Olaregen Therapeutix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Olaregen Therapeutix.